Radiation therapy (RT) is a valid treatment option for head and neck cancer (HNC). The risk of RT-induced toxicities is significant, especially due to extended treatment fields. The raise in amylase activity is strictly dependent on the volume of salivary glands included in the irradiated target volume and it is firmly related to the dose. The aim of this review is to report the effects on salivary amylase activity after radiation exposure of salivary glands, in patients with HNC.
Radiation therapy and serum salivary amylase in head and neck cancer / DE FELICE, Francesca; Tombolini, Mario; Musella, Angela; Marampon, Francesco; Tombolini, Vincenzo; Musio, Daniela. - In: ONCOTARGET. - ISSN 1949-2553. - ELETTRONICO. - 8:52(2017), pp. 90496-90500. [10.18632/oncotarget.18763]
Radiation therapy and serum salivary amylase in head and neck cancer
DE FELICE, FRANCESCA
Primo
;TOMBOLINI, MARIOSecondo
;MUSELLA, ANGELA;Marampon, Francesco;TOMBOLINI, VincenzoPenultimo
;
2017
Abstract
Radiation therapy (RT) is a valid treatment option for head and neck cancer (HNC). The risk of RT-induced toxicities is significant, especially due to extended treatment fields. The raise in amylase activity is strictly dependent on the volume of salivary glands included in the irradiated target volume and it is firmly related to the dose. The aim of this review is to report the effects on salivary amylase activity after radiation exposure of salivary glands, in patients with HNC.| File | Dimensione | Formato | |
|---|---|---|---|
|
De Felice_Radiation_2017.pdf
accesso aperto
Note: https://www.oncotarget.com/article/18763/text/
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
756.07 kB
Formato
Adobe PDF
|
756.07 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
